adenine has been researched along with incb-018424 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Arney, K | 1 |
Bjarnason, G; McCaw, L; Muhowski, EM; Shi, Y; Spaner, DE; Wang, C; Wang, G; Woyach, JA | 1 |
McCaw, L; Shi, Y; Spaner, DE; Tsui, H; Wang, G | 1 |
Ayuk, F; Ditschkowski, M; Gerbitz, A; Greinix, H; Halter, J; Hilgendorf, I; Holler, E; Jedlickova, Z; Klein, S; Kobbe, G; Lawitschka, A; Middeke, JM; Schäfer-Eckart, K; Stadler, M; Stelljes, M; Wagner-Drouet, E; Winkler, J; Wolff, D; Zeiser, R | 1 |
de Boer, R; de Weerdt, I; Eldering, E; Hofland, T; Kater, AP; Tannheimer, S; Ter Burg, H; Tonino, SH | 1 |
Harari, D; Luo, TY; Shi, Y; Spaner, DE; Tsui, H; Wang, G; Xia, M | 1 |
Tazi, I | 1 |
1 trial(s) available for adenine and incb-018424
Article | Year |
---|---|
Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cytokines; Female; Humans; Janus Kinase Inhibitors; Janus Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Male; Middle Aged; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction; Treatment Outcome | 2019 |
6 other study(ies) available for adenine and incb-018424
Article | Year |
---|---|
Solving lymphoma's stem-cell problem.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Allografts; Autografts; Azetidines; B-Lymphocytes; Cell Separation; Drug Approval; Fetal Blood; Graft vs Host Disease; Hodgkin Disease; Humans; Nitriles; Photopheresis; Piperidines; Problem Solving; Purines; Pyrazoles; Pyrimidines; Stem Cell Transplantation; Sulfonamides; T-Lymphocytes, Regulatory; United States; United States Food and Drug Administration | 2018 |
Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells.
Topics: Adenine; Biomarkers, Tumor; Circadian Rhythm; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nitriles; Phosphorylation; Piperidines; Pyrazoles; Pyrimidines; Receptors, Glucocorticoid; Toll-Like Receptors; Transcriptional Activation; Tumor Cells, Cultured; Tumor Microenvironment | 2019 |
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
Topics: Adenine; Adult; Austria; Bronchiolitis Obliterans; Chronic Disease; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Switzerland | 2019 |
Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Cell Survival; Humans; Imidazoles; Janus Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Mice; NIH 3T3 Cells; Nitriles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Quinazolinones | 2019 |
Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Drug Resistance, Neoplasm; Humans; Interferon Type I; Interferon-gamma; Leukemia, Lymphocytic, Chronic, B-Cell; Nitriles; Piperidines; Primary Cell Culture; Pyrazoles; Pyrimidines; Receptors, Interferon; Signal Transduction; Tumor Cells, Cultured | 2020 |
[Antineoplasic drug repurposing in hematology for COVID-19 treatment].
Topics: Adenine; Aniline Compounds; COVID-19 Drug Treatment; Drug Repositioning; Hematologic Neoplasms; Humans; Imatinib Mesylate; Janus Kinases; Nitriles; Oligopeptides; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinolines | 2021 |